Poor definitions threaten drug trial safety in India.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 23295999.
- Also identified by DOI 10.1038/nm0113-15.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
India has become a hotbed of clinical trials, but recent reports of safety lapses have prompted calls for better regulation in this area. Currently, trial requirements can be relaxed if doing so is in the 'public interest', but a clearer definition of what this means is needed before this provision should be used.
Medical subject headings
- Clinical Trials as Topic
- Government Regulation